ARCHIVES

Herceptin Recommended As Adjuvant For HER2 Positive Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 5 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Hisserich Named USC Assistant VP, Replaced By Rideout At Cancer Center; DeVita Assures Groups

June 27, 1986

NCI-Approved Clinical Trials

April 26, 2002

SBIR Solicitation Issued

September 13, 1996

In Brief: NCA to Hear Reports On Outstanding Investigator Awards, Defining QRA, P01 Guidelines, Gallow Work

May 6, 1983

In Brief: Greenwald Reorganizing DCPC, Elevates Surveillance to Program, Moves Branches

February 3, 1989

Group trials need prioritization, review, NCI official says.

July 25, 2003